Search - tctmd.com

Displaying 181 - 200 of 2439

Sort: Relevancy | Date

Presentation ESC 2024

DCB with rescue stenting versus intended stenting for de novo CAD: a multicenter, non-inferiority trial

Presenter: Ling Tao

September 02, 2024

Presentation ESC 2024

The EARTH-STEMI IPD meta-analysis

Presenter: Gianluca Campo

September 01, 2024

Presentation ESC 2024

The ASSURE DES Randomized Clinical Trial

Presenter: Jung-Min Ahn

August 31, 2024

Presentation Interventional Complications 2024

How to Treat Under-Deployed Stents

Presenter: Lorenzo Azzalini

August 03, 2024

Presentation Interventional Complications 2024

My Stent Isn’t on the Balloon Anymore (How to Avoid Losing a Stent)

Presenter: Darshan Doshi

August 03, 2024

Presentation Interventional Complications 2024

Dry-field Closure Tools and Techniques for the Non-Structuralist: Balloon Occlusion, Radial-to-Peripheral Equipment, and Covered Stents

Presenter: Logan Vincent

August 02, 2024

Presentation EuroPCR 2024

One-month DAPT followed by 5-month Ti - cagrelor monotherapy in acute coronary syndromes with DCB - results from REC-CAGEFREE II

Presenter: Ling Tao

May 15, 2024

Presentation EuroPCR 2024

Is coronary artery bypass surgery cost-effective compared with contemporary PCI? A FAME 3 analysis

Presenter: Frederik Zimmermann

May 15, 2024

Presentation EuroPCR 2024

Methodological Insight: REC-CAGEFREE II Trial

Presenter: Robert Byrne

May 14, 2024

Presentation EuroPCR 2024

Patient and procedure characteristics for 1000 Selution SLRTM sirolimus-eluting balloon procedures

Presenter: Simon Eccleshall

May 14, 2024

Presentation EuroPCR 2024

Randomised comparison of Abluminus DES+ sirolimus-eluting stents versus everolimus-eluting stents in coronary artery disease patients with diabetes mellitus global: the ABILITY diabetes global study

Presenter: Alexandre Abizaid

May 14, 2024

Presentation EuroPCR 2024

Site-specific antithrombotic therapy: DESyne BDS Plus study 12-month outcomes

Presenter: Alexandre Abizaid

May 14, 2024

Presentation EuroPCR 2024

Sirolimus vs paclitaxel DCB. A logistic regression analysis of EASTBOURNE and PEARL multicentre study

Presenter: Bernardo Cortese

May 14, 2024

Presentation Fellows 2024

Cutting-Edge Techniques in DCB Lesion Prep and Treatment

Presenter: Jeffrey W. Moses

April 13, 2024

Presentation Miami Valves 2024

Modern PCI: Achieve Optimal Treatment with AGENT DCB

Presenter: Yiannis S. Chatzizisis

February 03, 2024

Presentation Miami Valves 2024

AGENT™ Drug-Coated Balloon

Presenter: John M. Lasala

February 03, 2024

Presentation CTO 2024

The Dawn of Drug Coated Balloons, In-stent Restenosis, and Beyond

Presenter: Ajay J. Kirtane

February 03, 2024

Presentation CTO 2024

Breaking Barriers in Bifurcation PCI With Low LVEF: DES + DCB With Pioneering Percutaneous Ventricular Assist Device

Presenter: Carlos Campos

February 03, 2024

Presentation Miami Valves 2024

Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Balloon With Conventional Balloon Angioplasty for In-Stent Restenosis

Presenter: Thomas E. Noel

February 01, 2024

Presentation Miami Valves 2024

AGENT DCB Clinical Data

Presenter: Nicolas M. Van Mieghem

February 01, 2024

Advertisement

DCB with rescue stenting versus intended stenting for de novo CAD: a multicenter, non-inferiority trial

The EARTH-STEMI IPD meta-analysis

The ASSURE DES Randomized Clinical Trial

How to Treat Under-Deployed Stents

My Stent Isn’t on the Balloon Anymore (How to Avoid Losing a Stent)

Dry-field Closure Tools and Techniques for the Non-Structuralist: Balloon Occlusion, Radial-to-Peripheral Equipment, and Covered Stents

One-month DAPT followed by 5-month Ti - cagrelor monotherapy in acute coronary syndromes with DCB - results from REC-CAGEFREE II

Is coronary artery bypass surgery cost-effective compared with contemporary PCI? A FAME 3 analysis

Methodological Insight: REC-CAGEFREE II Trial

Patient and procedure characteristics for 1000 Selution SLRTM sirolimus-eluting balloon procedures

Randomised comparison of Abluminus DES+ sirolimus-eluting stents versus everolimus-eluting stents in coronary artery disease patients with diabetes mellitus global: the ABILITY diabetes global study

Site-specific antithrombotic therapy: DESyne BDS Plus study 12-month outcomes

Sirolimus vs paclitaxel DCB. A logistic regression analysis of EASTBOURNE and PEARL multicentre study

Cutting-Edge Techniques in DCB Lesion Prep and Treatment

Modern PCI: Achieve Optimal Treatment with AGENT DCB

AGENT™ Drug-Coated Balloon

The Dawn of Drug Coated Balloons, In-stent Restenosis, and Beyond

Breaking Barriers in Bifurcation PCI With Low LVEF: DES + DCB With Pioneering Percutaneous Ventricular Assist Device

Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Balloon With Conventional Balloon Angioplasty for In-Stent Restenosis

AGENT DCB Clinical Data

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content